Kathryn Penney

Research Associate

Harvard School of Public Health

Dr. Penney is a genetic and molecular epidemiologist. Her research focuses on identifying risk factors and predictors of prostate cancer development and progression. She is currently performing large-scale studies to identify genes and genetic variants that can distinguish indolent from lethal prostate cancer at diagnosis. She is particularly interested in combining different types of data, such as genetics, RNA and protein expression, and other biomarkers, to create a more comprehensive picture of the biology of prostate cancer incidence and progression.